Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Successful phase III trials of Cytolex trigger milestone payment for Magainin

June 11, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Micrologix Biotech enhancin restores activity of vancomycin

June 10, 1997

New antibacterial agents described by Zeneca

June 10, 1997

Generic aciclovir approved by FDA

June 9, 1997

In vitro activity of MEN-10700 assessed

June 5, 1997

3M to launch Aldara next week

June 5, 1997

Interferon Sciences announces distribution agreement for Alferon N Injection

June 3, 1997

Molecular structure of prostaglandins responsible for HSF1 activation elucidated

June 2, 1997

Ion channel-forming peptides from Magainin

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...